Company

ImCare Biotech is a biotechnology company founded in 2011 by Dr. Xuanyong Lu, formerly a professor at Drexel University’s Institute for Biotechnology and Virology.

The company’s primary products in development are innovative diagnostic biomarkers as well as developmental drugs for the treatment of liver diseases such as hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC).

ImCare Biotech’s main R&D center is located in Doylestown, PA, USA and includes a modern fully-equipped laboratory focused on molecular biology and tissue cultures. The company has an operational presence in the US.

Mission

To provide quality diagnostic and pharmaceutical products for the treatment of cancers, viral infections, and other long-term illnesses and improve the standard of care for patients and their loved ones. With research and innovation as the heart of our company, we hope to use deliver high-quality commercial products through smart and focused product development.

Vision

To be a leading biomedical technology company in the area of liver disease and liver cancer worldwide.